Share Facebook Twitter LinkedIn Pinterest Email Bristol Myers scraps Phase 3 study for Opdualog for colorectal cancer
Nasdaq weekly report: Micron Technology biggest gainer ahead of earnings, Thomson Reuters loses mostMarch 14, 2026
Retail investors pull back from equities, defying seasonal patterns, JP Morgan says (HOOD:NASDAQ)March 13, 2026